• D. Boral Capital Reaffirms "Buy" Rating for ImmunityBio (NASDAQ:IBRX)

    المصدر: Buzz FX / 16 يناير 2025 08:46:16   America/New_York


    D. Boral Capital Reaffirms "Buy" Rating for ImmunityBio (NASDAQ:IBRX) Written by MarketBeat January 16, 2025 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating restated by equities re
    Read more...
شارك على،